Journal of Cancer Therapy
Vol.4 No.6(2013), Paper ID 35135, 5
pages
DOI:10.4236/jct.2013.46126
Topotecan Use for Second-Line Treatment in Patients with Recurrent or Metastatic Cervical Cancer at Brazilian National Cancer Institute (INCA)
Leandro Nascimento de Oliveira, Flávia Vieira Guerra Alves, Paulo Alexandre Ribeiro Mora, Claudio Calazan do Carmo, Angélica Nogueira-Rodrigues, Alvaro Henrique Ingles Garces, Andréia Cristina de Melo
Instituto Nacional do Cancer, Hospital do Cancer II, Rio de Janeiro-RJ, Brazil
Instituto Nacional do Cancer, Hospital do Cancer II, Rio de Janeiro-RJ, Brazil
Instituto Nacional do Cancer, Hospital do Cancer II, Rio de Janeiro-RJ, Brazil
Instituto Nacional do Cancer, Hospital do Cancer II, Rio de Janeiro-RJ, Brazil
Instituto Nacional do Cancer, Hospital do Cancer II, Rio de Janeiro-RJ, Brazil
Instituto Nacional do Cancer, Hospital do Cancer II, Rio de Janeiro-RJ, Brazil
Instituto Nacional do Cancer, Hospital do Cancer II, Rio de Janeiro-RJ, Brazil
Copyright © 2013 Leandro Nascimento de Oliveira, Flávia Vieira Guerra Alves, Paulo Alexandre Ribeiro Mora, Claudio Calazan do Carmo, Angélica Nogueira-Rodrigues, Alvaro Henrique Ingles Garces, Andréia Cristina de Melo et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
L. Oliveira, F. Alves, P. Mora, C. Carmo, A. Nogueira-Rodrigues, A. Garces and A. Melo, "Topotecan Use for Second-Line Treatment in Patients with Recurrent or Metastatic Cervical Cancer at Brazilian National Cancer Institute (INCA),"
Journal of Cancer Therapy, Vol. 4 No. 6, 2013, pp. 1095-1099. doi:
10.4236/jct.2013.46126.